The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
T Cell Activation Is Associated with Lower CD4+T Cell Gains in Human Immunodeficiency Virus–Infected Patients with Sustained Viral Suppression during Antiretroviral Therapy
Open accessAbstract
Although T cell activation is associated with disease progression in untreated human immunodeficiency virus type 1 (HIV-1) infection, its significance in antiretroviral-treated patients is unknown. Activated (CD38+HLA-DR+) T cell counts were measured in 99 HIV-infected adults who had maintained a plasma HIV RNA level ⩽1000 copies/mL for a median of 21 months while receiving antiretroviral therapy. Patients with sustained viral suppression had lower levels of T cell activation than untreated patients but higher levels than HIV-uninfected control subjects. Persistent T cell activation was associated with decreased CD4+ T cell gains during therapy. For every 5% increase in the proportion of activated CD8+ T cells, 35 fewer CD4+ T cells/mm3 were gained. Increased T cell activation was associated with shorter duration of viral suppression, hepatitis C virus coinfection, frequent low-level viremia, and lower nadir CD4+ T cell counts. Interventions that directly target T cell activation or the determinants of activation may prove to be useful adjuvants to antiretroviral therapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Palella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J., & Holmberg, S. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381301 · Cited by 9,405
The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes
Bleul, C. C., Wu, L., Hoxie, J. A., Springer, T. A., & Mackay, C. R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.1925 · Cited by 1,134
Giorgi, J. V., Hultin, L. E., McKeating, J. A., Johnson, T. D., Owens, B., Jacobson, L. P., Shih, R., Lewis, J., Wiley, D. J., Phair, J. P., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/314660 · Cited by 1,033
Programmed Death of T Cells in HIV-1 Infection
Meyaard, L., Otto, S. A., Jonker, R. R., Mijnster, M. J., Keet, R. P. M., & Miedema, F. (1992) · Science · doi:10.1126/science.1352911 · Cited by 898
Detels, R. (1998) · JAMA · doi:10.1001/jama.280.17.1497 · Cited by 739
Harper, M. E., Marselle, L. M., Gallo, R. C., & Wong-Staal, F. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.3.772 · Cited by 725
Yeni, P. G., Hammer, S. M., Carpenter, C. C. J., Cooper, D. A., Fischl, M. A., Gatell, J. M., Gazzard, B. G., Hirsch, M. S., Jacobsen, D. M., Katzenstein, D. A., et al. (2002) · JAMA · doi:10.1001/jama.288.2.222 · Cited by 709
Pakker, N. G., Notermans, D. W., De Boer, R. J., Roos, M. T. L., Wolf, F. D., Hill, A., Leonard, J. M., Danner, S. A., Miedema, F., & Schellekens, P. T. A. (1998) · Nature Medicine · doi:10.1038/nm0298-208 · Cited by 701
CCR5 Levels and Expression Pattern Correlate with Infectability by Macrophage-tropic HIV-1, In Vitro
Wu, L., Paxton, W. A., Kassam, N., Ruffing, N., Rottman, J. B., Sullivan, N., Choe, H., Sodroski, J., Newman, W., Koup, R. A., et al. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.9.1681 · Cited by 694
Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans
Hellerstein, M., Hanley, M. B., Cesar, D., Siler, S., Papageorgopoulos, C., Wieder, E., Schmidt, D., Hoh, R., Neese, R., Macallan, D., et al. (1999) · Nature Medicine · doi:10.1038/4772 · Cited by 593
Self-citationCell dysfunction and depletion in AIDS: the programmed cell death hypothesis
Claude Ameisen, J., & Capron, A. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90092-8 · Cited by 530
Gougeon, M. L., Lecoeur, H., Dulioust, A., Enouf, M. G., Crouvoiser, M., Goujard, C., Debord, T., & Montagnier, L. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.9.3509 · Cited by 493
A cooperative interaction between NF-kappa B and Sp1 is required for HIV-1 enhancer activation.
Perkins, N. D., Edwards, N. L., Duckett, C. S., Agranoff, A. B., Schmid, R. M., & Nabel, G. J. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06029.x · Cited by 484
CD4+ T-cell depletion in HIV infection: Are we closer to understanding the cause?
Grossman, Z., Meier-Schellersheim, M., Sousa, A. E., Victorino, R. M. M., & Paul, W. E. (2002) · Nature Medicine · doi:10.1038/nm0402-319 · Cited by 450
Hazenberg, M. D., Otto, S. A., Stuart, J. W. T. C., Verschuren, M. C. M., Borleffs, J. C. C., Boucher, C. A. B., Coutinho, R. A., Lange, J. M. A., de Wit, T. F. R., Tsegaye, A., et al. (2000) · Nature Medicine · doi:10.1038/79549 · Cited by 394
T cell depletion in HIV-1 infection: how CD4+ T cells go out of stock
Hazenberg, M. D., Hamann, D., Schuitemaker, H., & Miedema, F. (2000) · Nature Immunology · doi:10.1038/79724 · Cited by 383
HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophages
Swingler, S., Mann, A., Jacqué, J.-M., Brichacek, B., Sasseville, V. G., Williams, K., Lackner, A. A., Janoff, E. N., Wang, R., Fisher, D., et al. (1999) · Nature Medicine · doi:10.1038/12433 · Cited by 368
Prevalence and Predictive Value of Intermittent Viremia With Combination HIV Therapy
Havlir, D. V. (2001) · JAMA · doi:10.1001/jama.286.2.171 · Cited by 358
Bucy, R. P., Hockett, R. D., Derdeyn, C. A., Saag, M. S., Squires, K., Sillers, M., Mitsuyasu, R. T., & Kilby, J. M. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5863 · Cited by 329
Cytokines and HIV infection: is AIDS a tumor necrosis factor disease?
Matsuyama, T., Kobayashi, N., & Yamamoto, N. (1991) · AIDS · doi:10.1097/00002030-199112000-00001 · Cited by 284
Poor CD4 T cell restoration after suppression of HIV-1 replication may reflect lower thymic function
Teixeira, L., Valdez, H., McCune, J. M., Koup, R. A., Badley, A. D., Hellerstein, M. K., Napolitano, L. A., Douek, D. C., Mbisa, G., Deeks, S., et al. (2001) · AIDS · doi:10.1097/00002030-200109280-00002 · Cited by 249
Self-citationFactors influencing T-cell turnover in HIV-1–seropositive patients
McCune, J. M., Hanley, M. B., Cesar, D., Halvorsen, R., Hoh, R., Schmidt, D., Wieder, E., Deeks, S., Siler, S., Neese, R., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8647 · Cited by 231
Self-citationHost Control of HIV-1 Parasitism in T Cells by the Nuclear Factor of Activated T Cells
Kinoshita, S., Chen, B. K., Kaneshima, H., & Nolan, G. P. (1998) · Cell · doi:10.1016/s0092-8674(00)81630-x · Cited by 227
Viard, J., Mocroft, A., Chiesi, A., Kirk, O., Røge, B., Panos, G., Vetter, N., Bruun, J. N., Johnson, M., Lundgren, J. D., et al. (2001) · The Journal of Infectious Diseases · doi:10.1086/319678 · Cited by 220
Expression of Chemokine Receptors CXCR4 and CCR5 in HIV-1-Infected and Uninfected Individuals
Ostrowski, M. A., Justement, S. J., Catanzaro, A., Hallahan, C. A., Ehler, L. A., Mizell, S. B., Kumar, P. N., Mican, J. A., Chun, T.-W., & Fauci, A. S. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.6.3195 · Cited by 217
Immune Hyperactivation of HIV-1-Infected T Cells Mediated by Tat and the CD28 Pathway
Ott, M., Emiliani, S., Van Lint, C., Herbein, G., Lovett, J., Chirmule, N., McCloskey, T., Pahwa, S., & Verdin, E. (1997) · Science · doi:10.1126/science.275.5305.1481 · Cited by 211
Valdez, H., Connick, E., Smith, K. Y., Lederman, M. M., Bosch, R. J., Kim, R. S., St. Clair, M., Kuritzkes, D. R., Kessler, H., Fox, L., et al. (2002) · AIDS · doi:10.1097/00002030-200209270-00002 · Cited by 211
Ribeiro, R. M., Mohri, H., Ho, D. D., & Perelson, A. S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242358099 · Cited by 198
bofill, M., mocroft, A., lipman, M., Medina, E., Borthwick, N. J., Sabin, C. A., Timms, A., Winter, M., Baptista, L., Johnson, M. A., et al. (1996) · AIDS · doi:10.1097/00002030-199607000-00005 · Cited by 181
Kaufmann, G. R., Bloch, M., Finlayson, R., Zaunders, J., Smith, D., & Cooper, D. A. (2002) · AIDS · doi:10.1097/00002030-200202150-00007 · Cited by 169
Smith, K. Y., Valdez, H., Landay, A., Spritzler, J., Kessler, H. A., Connick, E., Kuritzkes, D., Gross, B., Francis, I., McCune, J. M., et al. (2000) · The Journal of Infectious Diseases · doi:10.1086/315169 · Cited by 165
Rizzardi, G. P., Harari, A., Capiluppi, B., Tambussi, G., Ellefsen, K., Ciuffreda, D., Champagne, P., Bart, P., Chave, J., Lazzarin, A., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14522 · Cited by 159
Liu, Z., Hultin, L. E., Cumberland, W. G., Hultin, P. M., Schmid, I., Matud, J. L., Detels, R., & Giorgi, J. V. (1996) · Cytometry · Cited by 143
AIDS as immune system activation: a model for pathogenesis.
Ascher, M. S., & Sheppard, H. W. (1988) · PubMed Central · Cited by 127
Grossman, Z., Feinberg, M. B., & Paul, W. E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6314 · Cited by 123
Deeks, S. G., Hoh, R. A., Grant, R. M., et al. (2002) · The Journal of Infectious Diseases · doi:10.1086/338467 · Cited by 108
Self-citationThe Dominant Source of CD4+ and CD8+ T-Cell Activation in HIV Infection Is Antigenic Stimulation
Stuart, J. W. T. C., Hazebergh, M. D., Hamann, D., Otto, S. A., Borleffs, J. C. C., Miedema, F. F., Boucher, C. A., & de Boer, R. J. (2000) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200011010-00001 · Cited by 90
Lederman, M. M., McKinnis, R. A., Kelleher, D. L., Cutrell, A. G., Mellors, J. W., Neisler, M., Cooney, E. L., Haas, D. W., Haubrich, R., Stanford, J., et al. (2000) · AIDS · doi:10.1097/00002030-200012010-00002 · Cited by 77
Mikovits, J. A., Lohrey, N. C., Schulof, R. S., Courtless, J., & Ruscetti, F. W. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116016 · Cited by 70
Valdez, H., Anthony, D. D., Farukhi, F., Patki, A. H., Salkowitz, J. R., Heeger, P. S., Peterson, D. L., Post, A. B., Asaad, R. J., & Lederman, M. M. (2000) · AIDS · doi:10.1097/00002030-200010200-00004 · Cited by 70
Giorgi, J. V., Majchrowicz, M., Johnson, T. D., Hultin, P. M., Matud, J. L., & Detels, R. (1998) · AIDS · doi:10.1097/00002030-199814000-00015 · Cited by 68
Regulation of Human Immunodeficiency Virus Infection: Implications For Pathogenesis
Antoni, B. A., Stein, S., & Rabson, A. B. (1994) · Advances in virus research · doi:10.1016/s0065-3527(08)60047-0 · Cited by 60
Cyclosporine-induced deterioration in patients with AIDS.
Phillips, A. A., Wainberg, M. A., Coates, R. A., Klein, M., Rachlis, A., Read, S., Shepherd, F. A., Vellend, H., Walmsley, S. L., & Halloran, P. (1989) · Europe PMC (PubMed Central) · Cited by 48
Sousa, A. E., Chaves, A. F., Doroana, M., Antunes, F., & Victorino, R. M. M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.6.3718 · Cited by 46
CD38 Expression on CD8+ T Cells as a Prognostic Marker in Vertically HIV-Infected Pediatric Patients
Sherman, G. G., Scott, L. E., Galpin, J. S., Kuhn, L., Tiemessen, C. T., Simmank, K., Meddows‐Taylor, S., & Meyers, T. M. (2002) · Pediatric Research · doi:10.1203/00006450-200206000-00013 · Cited by 40
Capobianchi, M. R. (1996) · PubMed · Cited by 32
Shattock, R. J., Rizzardi, G. P., Hayes, P., & Griffin, G. E. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/174.1.54 · Cited by 28
Rizzardi, G. P., Harari, A., Capiluppi, B., Tambussi, G., Ellefsen, K., Ciuffreda, D., Champagne, P., Bart, P., Chave, J., Lazzarin, A., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200214522 · Cited by 26
Cited by
. Plasma levels of soluble CD14 independently predict mortality in HIV infection.
Sandler, N. G., Wand, H., Roque, A., Law, M., Nason, M. C., Nixon, D. E., Pedersen, C., Ruxrungtham, K., Lewin, S. R., Emery, S., et al. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiq118 · Cited by 1,106
Self-citationDeeks, S. G., Kitchen, C. M. R., Liu, L., Guo, H., Gascon, R., Narváez, A. B., Hunt, P., Martin, J. N., Kahn, J. O., Levy, J., et al. (2004) · Blood · doi:10.1182/blood-2003-09-3333 · Cited by 804
Self-citationNational Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2
Jacobson, T. A., Maki, K. C., Orringer, C. E., Jones, P. H., Kris-Etherton, P., Sikand, G., La Forge, R., Daniels, S. R., Wilson, D. P., Morris, P. B., et al. (2015) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2015.09.002 · Cited by 784
HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity.
Deeks, S. G., & Phillips, A. N. (2009) · BMJ · doi:10.1136/bmj.a3172 · Cited by 704
Feinstein, M. J., Hsue, P. Y., Benjamin, L. A., Bloomfield, G. S., Currier, J. S., Freiberg, M. S., Grinspoon, S. K., Levin, J., Longenecker, C. T., Post, W. S., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000695 · Cited by 658
Metadata
- Authors
- Hunt, P. W., Martin, J. N., Sinclair, E., Bredt, B., Hagos, E., Lampiris, H., & Deeks, S. G.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-05-15
- Volume
- 187
- Issue
- 10
- Pages
- 1534-1543
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2140573695
- Cited by
- 852
- References
- 48
- FWCI
- 7.13
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.